Drug Topics - November 5, 2007 - (Page 29)

29 DRUG TOPICS NOVEMBER 5, 2007 www.drugtopics.com CONTINUING EDUCATION An ongoing CE program of The University of Florida College of Pharmacy and DRUG TOPICS High-density lipoprotein: A new wave CE The University of Florida College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education ACPE # 012-99907-204-H01-P ACPE # 012-99907-204-H01-T Dana A. Brown, Pharm.D., Assistant Professor of Pharmacy Practice, Robert M. Thornby, Pharm.D. candidate, Palm Beach Atlantic University, Lloyd L. Gregory School of Pharmacy A This lesson is no longer valid for CE credit after 11/30/09. To obtain immediate CE credit, take the test on-line at www.drugtopics.com. Just click on the “Continuing Education” box on the Drug Topics home page, which will take you to the CE site. Log in, find and click on this lesson, and follow the three simple steps. Test results will be displayed immediately and you can print the certificate showing your earned CE credits. 51-year-old Hispanic female, J.K., was referred to your clinic for disease state management. She says that she is interested in gaining more education about her medications and how to live a healthier lifestyle. She confides in you and says, “My younger brother had a heart attack two months ago, and I am now really worried about my health as I feel it is beginning to spiral out of control.” Her medical history includes hypertension (HTN) for 20 years, Type 2 diabetes mellitus for eight years, and dyslipidemia for five years. She is also perimenopausal and reports mild hot flashes occurring about one time each month that are relieved by cold showers. J.K. hesitantly states that she does not monitor her blood glucose levels regularly. She has two HDL LDL LDL HDL LDL HDL HDL HDL HDL LDL LDL LDL HDL children, a husband, works a desk job, and lives a sedentary lifestyle. She has smoked cigarettes for more than 30 years and has failed multiple quit attempts. J.K. denies drinking alcohol, saying, “I was told to stay away from that stuff when they told me I had a sugar problem.” She has a sporadic diet and admits to eating fast food three times a week on average and cooking a lot of red meat for her husband and two “growing” boys. J.K.’s current medications include atenolol 50 p.o. mg daily, lisinopril 10 p.o. mg daily, glipizide/metformin 5/500 p.o. mg twice daily with meals, aspirin 81 mg p.o. daily, simvastatin 40 mg p.o. daily, and one multivitamin p.o. daily. J.K. also tells you that she had the influenza vaccine last week during a health fair at work. She reports that she has been taking all of her medications on time since her brother’s hospitalization, but before that she often forgot to take them and would run out of refills all the time. Upon assessment you determine J.K.’s blood pressure is 140/78 mmHg, pulse=72, weight=168 lb., and height=5’1”(BMI=31.7 kg/m2—obese). Lab tests from one week prior to today’s visit yielded electrolytes, renal function, and liver function tests within normal limits. Her A1c was 8.8% and fasting blood glucose was 210 mg/dl. The lipid panel included a total cholesterol (TC) of 155 mg/dl, low-density lipoprotein cholesterol (LDL-C) of 92 mg/dl, high-density lipoprotein cholesterol (HDL-C) of 35 mg/dl, and triglycerides (TG) of 140 mg/dl. J.K. wants to know, “What do all of these numbers mean? Should I be worried about having a heart attack like my brother?” What would you say to J.K.? For questions concerning PRINT CEs, call (352) 273-6275. For questions concerning ON-LINE CEs, call (866) 261-3558. llustration: Sandy Schultz http://www.drugtopics.com http://www.drugtopics.com

Table of Contents Feed for the Digital Edition of Drug Topics - November 5, 2007

Drug Topics - November 5, 2007 Contents Latebreakers Latebreakers in Depth Letters Rx Care Community Practice 150 Years of American Pharmacy Hospital Practice Pharmacists at Risk Government and Law High-Density Lipoprotein New Products Advertisers Index Classified Viewpoint

Drug Topics - November 5, 2007

For optimal viewing of this digital publication, please enable JavaScript and then refresh the page. If you would like to try to load the digital publication without using Flash Player detection, please click here.